POST Online Media Lite Edition


Currax Pharmaceuticals appoints Michael Kyle as SVP

Christian Fernsby |
Brentwood, Tenn., USA - Currax Pharmaceuticals, a specialty biopharmaceutical company, announced the appointment of Michael Kyle to the role of senior vice president, chief medical officer.

Article continues below

Prior to joining Currax, Dr. Kyle was the Head of Development at Jiangsu HengRui Pharmaceuticals, and before that he held various roles in both clinical development and medical affairs at Pfizer, including: US Medical Director of Established Products, Medical Affairs; Chief Medical Officer, Pfizer Consumer Health; and Vice President, Head of Global Clinical Services and Operations of Upjohn, a Pfizer Division.

Throughout his pharmaceutical career, Dr. Kyle has provided oversight and leadership for more than 300 phase I-IV trials as well as investigator-initiated studies.

Dr. Kyle earned his BS in Psychology from Loyola University and his Medical Degree from Rush Medical College.

He is a board-certified family physician and completed his residency training at West Suburban Family Medicine Residency Program in Oak Park, Illinois.